Science Translational Medicine · 2011 · 173 citations · 29 references
Life SciencesEndocrinologyMolecular BiologyCell SignalingDiabetologySignal TransductionAdipose TissueDiabetes MellitusGrowth Factor SignalingInsulin ResistanceInsulin Signaling In MetabolismPancreatic HormonesAdipose Tissue Glucose MetabolismBrown Adipose Tissue ActivationBrown Adipose Tissue BioenergeticsBrown Adipose Tissue MetabolismFibroblast Growth Factor Receptor SignalingInsulin Signaling PathwayInsulin-like Growth Factor Receptor SignalingInsulin-like Growth Factor-1
Clinical use of recombinant fibroblast growth factor 21 (FGF21) for the treatment of type 2 diabetes and other disorders linked to obesity has been proposed; however, its clinical development has been challenging owing to its poor pharmacokinetics. Here, we describe an alternative antidiabetic strategy using agonistic anti-FGFR1 (FGF receptor 1) antibodies (R1MAbs) that mimic the metabolic effects of FGF21. A single injection of R1MAb into obese diabetic mice induced acute and sustained amelioration of hyperglycemia, along with marked improvement in hyperinsulinemia, hyperlipidemia, and hepatosteatosis. R1MAb activated the mitogen-activated protein kinase pathway in adipose tissues, but not in liver, and neither FGF21 nor R1MAb improved glucose clearance in lipoatrophic mice, which suggests that adipose tissues played a central role in the observed metabolic effects. In brown adipose tissues, both FGF21 and R1MAb induced phosphorylation of CREB (cyclic adenosine 5'-monophosphate response element-binding protein), and mRNA expression of PGC-1α (peroxisome proliferator-activated receptor-γ coactivator 1α) and the downstream genes associated with oxidative metabolism. Collectively, we propose FGFR1 in adipose tissues as a major functional receptor for FGF21, as an upstream regulator of PGC-1α, and as a compelling target for antibody-based therapy for type 2 diabetes and other obesity-associated disorders.
29
FGF-21 as a novel metabolic regulator
Alexei Kharitonenkov, Tatiyana L. Shiyanova, Anja Köester et al. · Journal of Clinical Investigation · 2005 · 2.1K citations · Full text
CREB regulates hepatic gluconeogenesis through the coactivator PGC-1
Stephan Herzig, Fanxin Long, Ulupi S. Jhala et al. · Nature · 2001 · 1.4K citations
Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity
Yong‐Xu Wang, Chih‐Hao Lee, Sambath Tiep et al. · Cell · 2003 · 1.3K citations · Full text